Package 0093-3060-56

Brand: rasagiline

Generic: rasagiline
NDC Package

Package Facts

Identity

Package NDC 0093-3060-56
Digits Only 0093306056
Product NDC 0093-3060
Product ID 0093-3060_c26cc45d-41aa-456c-8b37-49420366d1f4
Description

30 TABLET in 1 BOTTLE (0093-3060-56)

Marketing

Marketing Status
Marketed Since 2017-01-03
Brand rasagiline
Generic rasagiline
Sample Package No

Linked Drug Pages (1)

Rasagiline ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c26cc45d-41aa-456c-8b37-49420366d1f4", "openfda": {"unii": ["LH8C2JI290"], "rxcui": ["608328", "636664"], "spl_set_id": ["e802c83c-e581-4a11-b83d-1df47120078d"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0093-3060-56)", "package_ndc": "0093-3060-56", "marketing_start_date": "20170103"}], "brand_name": "Rasagiline", "product_id": "0093-3060_c26cc45d-41aa-456c-8b37-49420366d1f4", "dosage_form": "TABLET", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]"], "product_ndc": "0093-3060", "generic_name": "Rasagiline", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rasagiline", "active_ingredients": [{"name": "RASAGILINE MESYLATE", "strength": ".5 mg/1"}], "application_number": "NDA021641", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20170103", "listing_expiration_date": "20261231"}